key: cord-0748475-5fu9d3s5
authors: Little, Brent P.
title: Disease Severity Scoring for COVID-19: A Welcome (Semi)Quantitative Role for Chest Radiography
date: 2021-09-14
journal: Radiology
DOI: 10.1148/radiol.2021212212
sha: eaa4600c0811a8a507a43d39ca426bbf96a7f4b5
doc_id: 748475
cord_uid: 5fu9d3s5

nan

Interest in quantitative medical imaging has accelerated, fueled by emergence of reliable and efficient computer software, assisted by machine learning and artificial intelligence. In thoracic imaging, examples of considerable research interest include tumor volume and texture analysis, lung/airway volumetrics, lung CT densitometry, and nodule measurement. Previous research on quantification and standardized grading of acute thoracic diseases has played an important but almost niche role over the past several decades, for example sporadic literature on CT quantification of acute respiratory distress syndrome (ARDS) and cardiogenic pulmonary edema (1) . While quantitative CT and MR applications in cardiovascular imaging have enjoyed full integration into routine radiologist workflow and reporting, clinical application of quantitative imaging in the thoracic realm is lagging. Historically, even simple disease severity scoring or grading systems have enjoyed only minor incorporation into radiology practice, such as the Scadding "stages" of sarcoidosis, certain cystic fibrosis scoring systems, and various attempts at pneumonia and edema grading. However, the COVID-19 pandemic has prompted compelling developments in the use of thoracic imaging to grade severity of acute pulmonary disease.

In this issue of Radiology, the study by Au-Yong et al provides elegant evidence of the feasibility and prognostic power of radiographic disease severity scoring systems in COVID-19 (2).

Although devastating, the COVID-19 pandemic has initiated a renaissance in imaging research on pneumonia, including quantitative and artificial intelligence applications to assist in diagnosis and Two of the lung scoring systems assessed by Au-Yong and colleagues were recently developed and validated by other groups. In 2018, Warren et al. described the RALE score, the sum of the products of extent and severity grades for each of 4 lung quadrants; the score ranges from 0-48 (6) . In an elegant proof of concept using a cohort of whole-lung specimens from 72 deceased lung transplant donors with contemporaneous chest radiographs, the group found a positive correlation between RALE scores and lung weights adjusted for body height. In a separate cohort of 174 patients from one of the ARDSNet trials, the group also found that higher RALE scores were independently associated with lower PaO2/FiO2 and higher mortality; in addition, with every 5-point decrease in RALE score, the adjusted hazard of death decreased by 16%. The Brixia score proposed by Borghesi et al. in 2020 is similar but I n p r e s s uses 6 zones and a slightly different grading of opacities, resulting in score ranging from 0-16. In 302 patients with COVID-19, the Brixia score (along with age and immunosuppressed status) was one of the few variables to show an independent correlation with in-hospital mortality. Impressively, the scoring system was actually put into routine clinical use at the authors' institution, with a score appended to the chest radiograph report (7) . Importantly, additional permutations of severity scoring were studied during the MERS (8) and SARS (9) outbreaks, with similarly promising results.

The study by Au-Yong et al provides further evidence of the potential value of chest radiograph severity scoring in COVID-19 and answers several key questions. First: what is the predictive power of severity scoring using imaging alone? The authors found that all severity scoring systems stratified patients by survival and escalation-free survival. Second: could the integration of chest radiograph scoring with clinical risk scores incorporating data such as vital signs, oxygenation status, and blood markers of inflammation improve the predictive power of models? The authors found the combination of clinical severity scoring systems and chest radiograph severity scoring improved model discrimination, with best results for the combination of National Early Warning Score 2 (NEWS2) and RALE scores, concordant with previous studies (4). Third, and perhaps most importantly from a practical consideration: is severity scoring feasible in terms of ease of training, reproducibility, and interpretability? The authors found that all systems could be used to score chest radiographs in under a minute each and found good intra-and inter-reader correlations in scores from all systems. Limitations were certainly present, such as the inclusion of only cases severe enough to merit hospitalization, but other studies have already shown relationships between higher chest radiograph severity scores and higher risk of poor outcomes in mild disease (4) . The study also raises questions about the balance between ease of use and predictive power of scoring systems, and one wonders if even simpler systems (such as unifocal vs. multifocal, unilateral vs. bilateral, etc.) could have similar results. The I n p r e s s generalizability of the prognostic power for COVID-19 variants of concern, such as the Delta variant, is also uncertain.

The study by Au-Yong and colleagues is part of a body of research supporting the status of chest radiograph severity scoring as an important prognostic marker that provides an index of the pulmonary effects of COVID-19. Au-Yong and colleagues also provide good evidence that severity scoring is reproducible and relatively rapid, capable of being integrated into a clinical workflow. Scoring was consistent across observers in different imaging subspecialties, with good inter-reader agreement between the scores of subspecialists in chest, breast, and gastrointestinal radiology. Although the quoted average times for scoring a single radiograph under all scoring systems were under one minute, the times could potentially be shorter with increasing reader experience (concordant with the personal experience of the author of this editorial).

In spite of the promising literature on severity scoring in COVID-19 and other acute pulmonary diseases, including the work by Au-Yong et al , chest radiograph and CT severity scoring are generally absent from most clinical radiology practice, and a devastating pandemic has so far done little to change this --why? A primary reason might be that despite years of research interest, potential clinical decision-making uses for such scoring systems are still unstudied and unproven. Should severity scores be used for triage, to make admission decisions, or to predict need to escalation of care to the intensive care unit? Should severity scores be used to help assess need for intubation? During peak admissions in hospital systems with limited resources, could chest radiograph severity assessment serve as an early warning system to predict need for resources hours or days in advance? Although clinical studies providing guidance about the effects of incorporating chest radiograph (or CT) disease severity scoring into clinical decision making are lacking, this may be a "first mover" problem. Routine use of severity scoring could trigger and facilitate such research, but skeptics await proof of clinical uses prior to implementation. Clinical use of such systems might be expected to grow in proportion to availability; I n p r e s s clinical insights might arise in the same way in which laboratory testing and patient telemetry can provide clinical guidance for patient management.

Implementation of routine reporting of radiographic severity scores for diseases such as COVID-19 pneumonia may meet skepticism in radiology. Adding tasks to growing workloads is seldom popular.

However, Au-Yong and colleagues show that severity scoring may be practical, potentially adding only seconds to a subset of chest radiograph reports. In addition, some groups have explored the use of artificial intelligence to provide automated severity scoring or to assist radiologists in scoring, with good correlation to human scoring and equivalent prognostic power (10) . Regardless of how scoring is performed, the practice might provide a welcome inclusion of (semi)quantitative information in the chest radiograph report, potentially replacing subjective terms like "extensive", "severe", "dense", or "mild", "patchy", "hazy". Perhaps studies from the COVID-19 pandemic like that of Au-Yong et al might finally encourage adoption of validated, standardized severity scoring systems, bringing fresh clinical relevance of a more quantitative role for the chest radiograph in the assessment and management of acute pulmonary disease. I n p r e s s

Lung recruitment in patients with the acute respiratory distress syndrome

Chest radiograph scoring alone or combined with other risk scores for predicting outcomes in COVID-19: A UK study

Chest CT score in COVID-19 patients: correlation with disease severity and short-term prognosis

Clinical and Chest Radiography Features Determine Patient Outcomes In Young and Middle Age Adults with COVID-19

Modelbased Prediction of Critical Illness in Hospitalized Patients with COVID-19

PubMed Central

Severity scoring of lung oedema on the chest radiograph is associated with clinical outcomes in ARDS

Chest X-ray severity index as a predictor of in-hospital mortality in coronavirus disease 2019: A study of 302 patients from Italy

Clinical implication of radiographic scores in acute Middle East respiratory syndrome coronavirus pneumonia: report from a single tertiaryreferral center of South Korea

Value of initial chest radiographs for predicting clinical outcomes in patients with severe acute respiratory syndrome

Pulmonary Disease Severity on Chest Radiographs using Convolutional Siamese Neural Networks. Radiol Artif Intell